Lamperski Brendan MD Allison Park, PA - 15101

Lamperski Brendan MD is categorized under Internal Medicine Doctors in Allison Park, PA and active since 2004.

Lamperski Brendan MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Brendan Lamperski at the company’s single location by writing to 4068 Mount Royal Boulevard # 101, Allison Park, Pennsylvania PA 15101 or by phoning (412) 486-3076. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lamperski Brendan MD
Contact Person: Brendan Lamperski
Address: 4068 Mount Royal Boulevard # 101, Allison Park, Pennsylvania 15101
Phone Number: (412) 486-3076
Annual Revenue (USD): $500.000 to $999.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lamperski Brendan MD was started in 2004 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Brendan Lamperski for inquiries that concern Lamperski Brendan MD by calling the company number (412) 486-3076, as your correspondence is most welcome. Additionally, the physical location of the single location of Lamperski Brendan MD can be found at the coordinates 40.566023,-79.964601 as well as the street address 4068 Mount Royal Boulevard # 101 in Allison Park, Pennsylvania 15101.

For its online presence, you may visit Lamperski Brendan MD’s website at and engage with its social media outlets through on Twitter and on Facebook.